News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst upgraded Centrus Energy to Buy after a pullback, recommending a tactical long.
  • Centrus's $4.5 billion backlog remains, supporting 2026 revenue guidance.
  • Centrus holds a unique position in HALEU supply, relevant to advanced reactor fuel demand.
  • The recommended trade targets a rebound to fairer multiples while emphasizing defined risk controls.
  • ADARx priced 26.25 million shares at $17 each, raising about $446.3 million in its Nasdaq IPO under ticker ADRX.
  • AbbVie agreed to buy up to $100 million of ADARx stock in a private placement, potentially lifting proceeds to $535.2 million.

Latest Articles

Eurozone Households Still Hoarding Cash as Savings Rate Remains Elevated

Eurozone Households Still Hoarding Cash as Savings Rate Remains Elevated

Eurozone households maintained a substantially higher savings rate in the first quarter of 2026 than in the five years preceding the pandemic, limiting consumer spending and acting as a drag on economic growth, ING Economics said in a note dated Friday. The gross savings ratio held at 14.26%, leaving households spending roughly €85.74 per €100 of d…

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced it has submitted a formal response to the U.S. Department of Health and Human Services' Request for Information regarding its MEAI-based neuroplastogen therapy, CMND-100, targeting Alcohol Use Disorder (AUD). The company emphasizes its approach offering a scalable, l…

Who Warsh Put in Charge: The 15 Experts Leading the Fed Review

Who Warsh Put in Charge: The 15 Experts Leading the Fed Review

Federal Reserve Chairman Kevin Warsh named 15 experienced economists, policymakers and private-sector leaders to head five taskforces reviewing the central bank’s policy operations. The group spans former central bankers, academics, and business executives and will lead teams focused on communications, balance sheet policy, data, productivity and j…

FAST TRACK GROUP Secures Strategic Capital to Support Next Phase of Entertainment and Media Growth

FAST TRACK GROUP Secures Strategic Capital to Support Next Phase of Entertainment and Media Growth

FAST TRACK GROUP announced a successful closing of $1.5 million senior secured convertible note financing and a $20 million equity line of credit with a U.S. institutional investor. The capital will be used to pursue strategic partnerships, artist and intellectual property deals, digital content and media development, and other initiatives aimed at…

Wrap Technologies Inc. (NASDAQ: WRAP) Enters Strategic Transaction, Acquires US and NATO Distribution Rights to Physics-Based Sensing Tech

Wrap Technologies Inc. (NASDAQ: WRAP) Enters Strategic Transaction, Acquires US and NATO Distribution Rights to Physics-Based Sensing Tech

Wrap Technologies Inc. has entered into a strategic transaction to acquire exclusive US and NATO distribution rights to a physics-based sensing technology from Frenel Imaging Ltd. This technology enhances the detection and response capabilities of Wrap's emerging WrapShield counter-UAS platform. The move strengthens Wrap's portfolio of public safet…

SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders

SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders

SRX Global, Inc. (NYSE American: SRXH) announces a virtual fireside chat to discuss key recent developments including the completion of the EMJX acquisition, establishing the company as an AI-enabled platform focused on delivering shareholder value through diverse high-conviction operating assets and technology-enabled investments. The company has …

Premarket Movers: CCC, Circle, Meta Strengthen; Silo and Fermi Retreat

Premarket Movers: CCC, Circle, Meta Strengthen; Silo and Fermi Retreat

U.S. stock index futures were modestly lower on Friday as investors digested gains from a recent relief rally. Softer crude oil prices and signs of potential diplomatic progress between Washington and Tehran contributed to steadier sentiment. Market attention concentrated on AI and software names, regulatory approvals, takeover speculation and fres…

Global Equity Flows Jump to Three-Week High on AI Optimism and Softer Fed Bets

Global Equity Flows Jump to Three-Week High on AI Optimism and Softer Fed Bets

Global equity funds registered their largest weekly net inflow in three weeks in the period ending July 8, driven by strong demand for AI-related technology products and a decline in expectations for further Federal Reserve rate hikes. Technology funds led the move, even as bond and money-market allocations also saw sizable purchases.

Forte Biosciences: FB-102 Is Graduating Into a Platform Narrative — Trade the Re-rate, Defend With Stops

Forte Biosciences: FB-102 Is Graduating Into a Platform Narrative — Trade the Re-rate, Defend With Stops

Forte Biosciences is trading like a breakout biotech. Technical momentum and increasing short interest have produced a quick re-rate; the investment case now hinges on FB-102 being positioned as a platform that can drive multiple clinical programs. This trade idea recommends a tactical long with a clearly defined stop and target, while outlining th…

Silo Pharma Shares Slide After Nasdaq-Rule Private Placement Announcement

Silo Pharma Shares Slide After Nasdaq-Rule Private Placement Announcement

Silo Pharma Inc. reported a private placement under Nasdaq rules that will issue common shares and two series of warrants, prompting a 22% drop in the company's stock. The offering is structured to raise roughly $4 million upfront, with potential additional proceeds if warrants are exercised, and is set to close around July 10, 2026, subject to cus…

ICC deputy prosecutor announces evidentiary breakthrough in Darfur probes

ICC deputy prosecutor announces evidentiary breakthrough in Darfur probes

The International Criminal Court says investigators have obtained what it describes as strong new evidence linking atrocity crimes committed in Darfur to leadership levels. Deputy prosecutor Nazhat Shameem Khan, following a visit to victims in eastern Chad, said the material represents a breakthrough for ongoing probes into attacks in al-Geneina in…

Buying Porsche ADRs Here: A Patient Long With Asymmetric Upside

Buying Porsche ADRs Here: A Patient Long With Asymmetric Upside

Porsche Automobil Holding SE's ADR (POAHY) is trading near its 52-week low on thin OTC liquidity but at compelling accounting multiples: market cap ~$9.35B, P/E ~3.2, and P/B ~0.21. With a modest dividend, a near-term payable date, depressed technicals (RSI ~33) and elevated short activity, the name presents an asymmetric risk/reward for patient lo…

Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases

Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases

Greenland Mines Ltd announced that Australia's IP Australia has granted a patent for its Biotech Division's Klotho gene therapy technology designed to treat neuromuscular diseases including ALS. The patent covers novel gene therapy methods using muscle-cell specific promoters and delivery systems such as viral vectors, reinforcing the company's Int…

Cove Kaz Capital Group Begins Site Preparation at Northern Katpar in Support of Final Drilling for the Definitive Feasibility Study

Cove Kaz Capital Group Begins Site Preparation at Northern Katpar in Support of Final Drilling for the Definitive Feasibility Study

Cove Kaz Capital Group has commenced site preparation activities at the Northern Katpar tungsten deposit in Kazakhstan to support the final drilling and Definitive Feasibility Study (DFS). These efforts are part of advancing one of the world’s largest undeveloped tungsten projects, with plans to produce approximately 12,000 metric tonnes per annum.…